CD163 and Parkinson disease: Neither serum‐ nor CSF‐sCD163 correlated with other clinical parameters [Unified Parkinson's Disease Rating Scale part III (UPDRS‐III) or Levodopa Equivalent Daily Dose (LEDD)] after compensating for covariables (data not shown).